Clinical Trial Update: A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the bioequivalence of Apotex's azelastine hydrochloride and fluticasone propionate nasal spray to Dymista for seasonal allergic rhini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (azelastine hydrochloride; fluticasone propionate nasal spray)
• Dymista Nasal Spray (azelastine hydrochloride and fluticasone propionate nasal spray)

Snippet

Sponsor: Apotex Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: UNKNOWN